Navigation Links
AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results
Date:3/11/2009

, except per share data) 2008 2007 2008 2007 2006 ------------------------------------------------------------------------- ------------------------------------------------------------------------- $ $ $ $ $ Revenues Sales and royalties 4,640 6,435 29,462 28,825 25,123 License fees 2,092 3,705 8,504 12,843 13,652 Other 512 100 512 400 24 ------------------------------------------------------------------------- 7,244 10,240 38,478 42,068 38,799 ------------------------------------------------------------------------- Operating expenses Cost of sales 4,930 3,255 19,278 12,930 11,270 Selling, general and administrative expenses 3,038 5,146 17,325 20,403 16,478 Research and development costs 12,328 13,574 57,448 39,248 27,422 R&D tax credits and grants (137) (1,941) (343) (2,060) (1,564) Depreciation and amortization Property, plant and equipment 316 378 1,515 1,562 2,816 Intangible assets 3,084 757 5,639 4,004 6,148 Impairment of long-lived asset held for sale - 735 - 735 - ------------------------------------------------------------------------- 23,559 21,904 100,862 76,822 62,570 ------------------------------------------------------------------------- Loss from operations (16,315) (11,664) (62,384) (34,754) (23,771) ------------------------------------------------------------------------- Other income (expenses) Interest income 1
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York
3. AEterna Zentaris Announces Outcome of Managements Strategic Review
4. AEterna Zentaris to Further Develop Three Follow-up Multi-targeted Cytotoxic Candidates to AEZS-112 as Potential Novel Cancer Treatment
5. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
6. AEterna Zentaris to Present at the Upcoming Roth Capital Partners 20th Annual OC Growth Stock Conference in Dana Point, California
7. Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2007 Financial and Operating Results on March 5, 2008
8. AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs
9. AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
10. Aeterna Zentaris Reports Fourth Quarter and Full-Year 2007 Financial and Operating Results
11. Aeterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... , , Collaboration to Create Optimized Antibodies ... Cancer , MISSISSAUGA, ON, Dec. 10 /PRNewswire-FirstCall/ - YM ... results of a collaborative program between YM and the ... Institute (NRC-BRI). Utilizing YM,s IntelliMab(TM) technology, the program is ...
... challenges miniaturizing transistors, the key active components in nearly ... or switch electronic signals. Now, ... and Applied Science, Purdue University and IBM have successfully ... transistors. These nanowires which ...
... - Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today ... Officer, replacing Dr. Brad Popovich. , "We want to thank ... the last four years. Brad has taken the Company from ... of time. Brad has also managed to recruit one of ...
Cached Biology Technology:YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 2New silicon-germanium nanowires could lead to smaller, more powerful electronic devices 3Sirius Genomics Announces Change in Leadership 2
(Date:11/18/2014)... 2014   News Highlights: ... develop The Partners Data Lake, an agile data ... Lake will allow researcher and clinicians to explore ... the lives of patients , The Partners ... across the Partners system, breaking down physical barriers ...
(Date:11/15/2014)... YORK , Nov. 13, 2014  While we may ... technology Doctor McCoy used in "Star Trek" to gain instant ... tools designed to work with smartphones and tablets for monitoring ... of the healthcare world. This may seem a tad Orwellian ... ready to adopt some of these technological opportunities into their ...
(Date:11/10/2014)... appearing on U.S. store shelves in early 2010, and ... The small packets can be tossed into a washing ... or powder. The convenience, though, has come with risks ... at Nationwide Children,s Hospital found that from 2012 through ... children younger than 6 years of age swallowing, inhaling, ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Americans May Be Ready for a Brave New World of Healthcare 2Americans May Be Ready for a Brave New World of Healthcare 3Americans May Be Ready for a Brave New World of Healthcare 4Study finds laundry detergent pods, serious poisoning risk for children 2
... - In the July issue of Biomaterials , ... Florida (UCF) report on the first lab-grown motor nerves ... in the human body. The model system will ... such as diabetic neuropathy and later, possibly multiple sclerosis ...
... (BOSTON) July 21, 2009 - A menace to ... the World Organisation for Animal Health (OIE) has declared ... cattle-killing disease that threatened its food supply and its ... July 25, 2009. A team from Tufts University,s ...
... , This release is available in German ... enriching samples, then separating, identifying, and counting the bacteria. This ... arrival of the sample in the laboratory. Tests that work ... being precise and error-free, are thus high on the wish ...
Cached Biology News:Researchers design first model motor nerve system that's insulated and organized like the human body 2Ethiopian government celebrates rinderpest eradication 2Ethiopian government celebrates rinderpest eradication 3Reveal the enemy 2
... magnetic particle based purification systems provide high ... any sample. They offer increased throughput and ... systems- KingFisher, KingFisher mL and KingFisher 96, ... l. Each system consists of an instrument, ...
... The DNA120OP is specifically engineered for ... sturdy design incorporates a glass cover and ... fully automated, unattended, odor-free processing of samples ... System for Synthetic Oligos ...
... The SPD101B is a no-frills, basic ... institution. Although economically priced, this unit still ... with a digitial display of time and ... aqueous samples and accepts a wide variety ...
... The first SpeedVac to have active, ... Explorer SpeedVac System is the worlds first, ... components can be stacked together to form ... valuable benchspace. It is also the first ...
Biology Products: